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.2012.10.Abstract Hyaluronidase ‘‘venom spreading factor’’ is a common component of snake venoms and
indirectly potentiates venom toxicity. It may cause permanent local tissue destruction at the bite
site/systemic collapse of the envenomated victim. The present study was performed to assess the
beneﬁts of inhibiting the hyaluronidase activity of Egyptian horned viper, Cerastes cerastes (Cc).
The aqueous extracts of some medicinal plants were screened for their inhibitory effect on hyaluron-
idase activity of Cc venom. The results revealed that the Rosmarinus ofﬁcinalis (Ro) extract is the
most potent hyaluronidase inhibitor among the tested extracts. The Ro extract is more potent inhib-
itory effect on the hyaluronidase activity than the prepared rabbit monoclonal antiserum of previ-
ously puriﬁed hyaluronidase enzyme from Cc venom (anti-CcHaseII). In addition, the Ro extract is
efﬁciently inhibited the activity of hemorrhagic toxin previously puriﬁed from Cc venom, and it also
neutralized the edema inducing activity of the Cc venom in vivo. Furthermore, the Ro extract mark-
edly increased the survival time of experimental mice injected with lethal dose of Cc venom up to 7 h
in compared to mice injected with venom alone or with venom/anti-CcHaseII (15 ± 5, 75 ± 4 min),
respectively. Our ﬁndings imply the signiﬁcance of plant-derived hyaluronidase inhibitor in the neu-
tralization of local effects of Cc venom and retardation of death time. Therefore, it may use as a
therapeutic value in complementary snakebite therapy.
ª 2012 Academy of Scientific Research & Technology. Production and hosting by Elsevier B.V.
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enter, Egypt.
g by Elsevier
c Research & Technology. Produc
0011. Introduction
Snake’s envenomation is a serious socio-medical problem,
especially in the places where snakes are abundant, with an
estimated 1.8–2.5 million incidences per year, a mortality level
of 100,000–125,000 persons annually and more than 100,000tion and hosting by Elsevier B.V. All rights reserved.
214 A.F. Wahby et al.individuals suffering from severe complications, which may
end in amputation of the attacked limb [22,36]. In Egypt,
approximately 1000–10,000 envenomings per year with about
11–100 persons are estimated to die annually [22].
The Egyptian desert horned viper (genus Cerastes) is the
best known, most distinctive and most abundant venomous
snakes of the great deserts of North Africa and the Middle
East. This viper is popular among snake-keepers and thus
encountering snakebite is not rare outside the area of its ori-
ginal distribution [11,43]. Envenomings by Cerastes viper in-
ﬂict prominent local tissue damage, which disrupts the
extracellular matrix and basement membrane surrounding
blood vessels and capillaries that are essential for rapid dis-
semination of target-speciﬁc toxins. Therefore, locally acting
factors, especially hyaluronidases, hemorrhagic metallopro-
teinases and myotoxins (enzymatic/non-enzymatic) have been
received more attention [2,16]. These spreading factors are
facilitating the diffusion of toxins into the circulation leading
to systemic effects, which include spontaneous hemorrhage–
cerebral hemorrhage being the most serious manifestation
deﬁbrinogenation, disseminated intravascular coagulation,
and cardiovascular shock secondary to hypovolaemia, vaso-
dilation, and direct effects on the myocardium, acute renal
failure and acute respiratory distress syndrome [48]. It is
likely that inhibition of these enzymes will not only minimize
local tissue damage such as hemorrhage, edema, necrosis and
inﬂammation in site of the bite, but will also retard the dis-
tribution of lethal toxins; hence their importance in the man-
agement of snakebite.
Although the available antivenom neutralizes the active
venom components, stopping further damage but do not re-
verse the damage already done [26–28,52]. It is important
to search for different venom inhibitors, either synthetic or
natural, which would complement the action of antivenom,
particularly in relation to the neutralization of local tissue
damage. Hence, hyaluronidase is an important target for
minimizing envenomation-associated morbidity, so the inhibi-
tion of hyaluronidase not only prevents local tissue destruc-
tion but also retards the diffusion of toxins into the blood,
resulting in delay in time to death in severe cases of envenom-
ation [13,14,53].
Compounds such as proteins, glycosaminoglycans, polysac-
charides, ﬂavonoids, alkaloids, antioxidants, anti-inﬂamma-
tory agents, and synthetic organic have been investigated as
hyaluronidase inhibitors. [12–14,23,25,29,33,35,40,44,53]. In
addition, aqueous, methanolic or ethanolic extracts prepared
to different parts of numerous plant species have been investi-
gated as hyaluronidase inhibitors [9,15,18,30,38,39,47]. In pre-
viously study, novel hyaluronidase CcHaseII (33 kDa) of the
most dangerous horned viper Cerastes cerastes was puriﬁed
and characterized in a set of biochemical assays. CcHaseII en-
hanced one hundred percent of hemorrhagic activity of the po-
tent puriﬁed hemorrhagic SVMP of corresponding venom and
the antiserum prepared against it showed highly cross-reactiv-
ity with many of the Egyptian snake venom proteins [51]. This
study aims to screen the aqueous extracts of different common
medicinal herbs for their inhibitory effect on the hyaluronidase
activity of Cc venom. Select the most potent inhibitor among
the tested extracts as a natural inhibitor and studies its role
for inhibition of hemorrhagic activity, edema inducing activity
and lethality of the Cc venom.2. Materials and methods
2.1. Collection of medicinal plants
Plants names and their families: (Cuminum cyminum, Foenicu-
lum vulgare, Pimpinella anisum; Apiaceae), (Ceratonia siliqua,
Glycyrrhiza glabra, Tamarindus indica; Fabaceae), (Mentha
peprinta, Ocimum basilicum, Origaum majorana, Rosmarinus
ofﬁcinalis, Thymus monglicus; Lamiaceae), (Hibiscus sabda-
riffa; Malvaceae; Sesamum inddicum; Pedaliaceae), (Hordeum
vulgare; Poaceae), (Nigella sativa; Ranunculaceae), and (Cur-
cuma longa, Zingiber ofﬁciale; Zingiberaceae). All plants for
the present study were obtained from Agricultural Research
Center, Dokki, Egypt.
2.2. Extraction of plants
Air-dried plant material collected, washed thoroughly with
water, shade-dried and grounded into coarse powder. Five
grams of the powdered shade dried plant material was soaked
in 50 ml distilled water (w/v) overnight at room temperature
with constant stirring. The obtained extract was ﬁltered using
Whatman ﬁlter paper No. 1, the residue obtained was re-
suspended in freshly distilled water (1:2 ratios). The process
was repeated three times. Then, crude extracts were centri-
fuged at 3000 rpm for 10 min, and were stored in tightly stop-
per bottles at 4 C for further study.
2.3. Animals
Male Swiss albino mice weighting 20 ± 1 g were used for
lethality test. Albino and Swiss rabbits weighting (1, 1.5 kg)
were used for hemorrhagic test and antiserum preparation,
respectively. The animals were obtained from the laboratory
animal (National Research Centre). They housed in stainless
steel cages at room temperature (28–32 C) under a light peri-
od of 16–18 h daily and fed on standard commercial feed. The
experiments were carried out in the same lab in accordance
with the institutional guidelines for animal care and use.
2.4. Snake venom and chemicals
Venom of C. cerastes (Cc) was milked from adults collected
from the ﬁeld. The venom was lyophilized and stored at
20 C. Samples were thawed and centrifuged before use.
CcHaseII, hyaluronidase enzyme previously puriﬁed and char-
acterized from Cc venom [51] Rooster comb hyaluronic acid
(HA) and cetyltrimethylammonium bromide (CTAB) were ob-
tained from Sigma. All other chemicals and reagents were of
analytical grade. The buffers were prepared according to
Gomorie [17] and Blanchard [6] and the ﬁnal pH was checked
by pH meter (Hanna, pH 211 Microprocessor pH meter).
2.5. Immunization of rabbits and preparation of CcHaseII
antiserum
According to a low dose and low volume immunization proto-
col assessed by Chotwiwatthanakun et al. [10] with slight mod-
iﬁcation. Two male Swiss rabbits (1.5 kg) were injected
intramuscularly with dose containing 10 lg of CcHaseII dis-
solved in 0.5 ml isotonic saline. The primer dose was emulsiﬁed
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ﬁrst and second booster doses were emulsiﬁed with 0.5 ml of
incomplete Freund’s adjuvant (IFA). Blood samples of the
individual rabbits were collected at one-week intervals, left
overnight at 4 C, centrifuged at 3000 rpm for 10 min to sepa-
rate the antisera. Sera samples before immunization were used
for control purposes.
2.6. ELISA procedure
ELISA was performed according to the method of Maria et al.
[32] Brieﬂy, ELISA plates were incubated overnight at 4 C
with 0.1 ml of 0.5 lg Cc venom dissolved in 50 mM sodium
carbonate; pH 9.6. After blocking and washing, 100 ll/well
of each serial dilution from the non-immune and the immune
rabbit sera dissolved in washing buffer were incubated at
37 C for 1 h. The plates were washed and incubated with
100 ll/well of anti-rabbit IgG (whole molecule) peroxidase
conjugate, diluted (1:5000) for 1 h at 37 C. Then the wells
were washed and 100 ll of substrate buffer (0.33 mg OPD/ml
dissolved in citrate buffer, pH 5.2 containing 0.04% hydrogen
peroxide) were added. The reaction was stopped after 20 min
by the addition of 20 ll of a 1:20 dilution of sulfuric acid,
and the absorbance values were determined at 490 nm with
the ELISA reader photometer (Titrec Multiscan, Flow Labo-
ratories). All the values were recorded in duplicate, and the
mean results were obtained. The dilution that gives 0.5 at
490 nm (OD) was taken as the endpoint for calculation of
the ELISA titer in ELISA units (EU), calculated as reciprocal
of the dilution at the end.
2.7. In vitro inhibition of the hyaluronidase activity of Cc venom
Hyaluronidase enzyme activity was determined turbidimetri-
cally by the method of Pukrittayakamee et al. [41]. For inhibi-
tion studies, the Cc crude venom (10 lg) and puriﬁed CcHaseII
(1.75 lg) were pre-incubated separately with various watery
plant extracts for 15 min at 37 C. Then, the mixture was
added to 50 lg of hyaluronic acid in 0.2 M sodium acetate buf-
fer, pH 5.5 containing 0.15 M NaCl at 37 C for 15 min prior
addition of 1 ml of stopping reagent (2.5% CTAB in 2%
NaOH). The absorbance was monitored at 400 nm. The ve-
nom and reaction mixture without plant extract or anti-CcHa-
seII were referred as control or 100% activity.
2.8. Inhibition of Cc venom spreading property
Hemorrhagic activity was determined according to the method
of Kondo et al. [24]. The back of an albino rabbit was shaved
and after overnight incubation, samples were injected dorsally
and intradermally in 100 ll of saline. Sample 1, one unit (1U)
of hemorrhagic CcHTI (1.9 lg) previously puriﬁed and charac-
terized from Cc venom alone [50]. Sample 2, 1U of
CcHTI+1U CcHaseII, sample 3, 1U CcHTI+1U CcHaseII
individually pre-incubated for 5 min at 37 C with 50 ll of
Ro extract. Sample 4, 5 and 6, CcHaseII (1U), Ro extract
(50 ll), and saline (100 ll) alone serve as controls, respectively.
The next day, the skin was rapidly removed, ﬁxed on a glass
plate and the diameter of each hemorrhagic spot was measured
and compared with the control. Results were expressed as
mean hemorrhagic diameters (mm) ±SEM.2.9. Edema-inducing activity
The edema inducing activity assayed according to the method
of Vishwanath et al. [49] with slight modiﬁcations. Groups of 5
male Swiss mice (20 ± 1 g)were injected individually in the
right footpads with two-times the minimum edema dose
(2MED) of Cc venom (8 lg) in 100 ll saline, and the left foot-
pads received equal volume of saline as controls. Inhibition
studies were performed by preincubtation of 2MED of Cc with
Ro extract at 1:0,1:10, 1:20, 1:30, 1:40, 1:50 ratios at 37 C for
15 min before injection. The mice were anesthetized by diethyl
ether inhalation; the legs were removed at the ankle joint after
1 h increase in weight due to edema was calculated as edema
ratio, which equals the weight of edematous leg · 100/weight
of control leg. The MED deﬁned as the amount of venom re-
quired to cause an edema ratio of 120%.
2.10. Lethal potency and neutralization of lethal toxicity of Cc
venom
LD50 was determined according to the method of Meier and
Theakston [34]. Five groups of male Swiss albino mice
(n= 5) 20 ± 1 g were injected intraperitonially (i.p.) with Cc
venom in 0.3 ml of saline with the doses ranging from 2 to
64 lg, and control group has received only saline. Survival
time of each animal in each set was recorded for 24 h. LD50
was calculated as the venom dose that killed 50% of animals.
For neutralization studies, the effects of the plant extract (Ro)
and prepared anti-CcHaseII on the lethal potency of Cc stud-
ied by six groups of mice (n= 5). Group I received 2LD50 of
venom alone. Group II and group III each divided to ﬁve sub-
groups (a–e), in which either anti-CcHaseII or Ro-extract in-
jected i.p. immediately after 2LD50 venom injection, with
ratios (w/w) of 1:20, 1:40, 1:80, 1:160 and 1:320 in a–e, respec-
tively. Groups IV, V and VI received anti-CcHaseII, Ro-ex-
tract and saline alone, respectively, as control groups. The
mice were constantly observed for symptoms/signs of toxicity,
and the survival time was recorded.
2.11. Protein determination
Protein concentrations were determined according to the
method of Bradford [8], using bovine serum albumin as a stan-
dard protein.
2.12. Statistical analysis
Each experiment was repeated thrice and the data in this study
are presented as mean ± SEM.
3. Results and discussion
Edema, hemorrhage and necrosis associated with extensive tis-
sue damage are the characteristic symptoms of Cc envenoma-
tion. In addition, the envenomation systemically affects
hemostasis resulting in bleeding disorders [43,48]. In view of
the limitations of antivenom therapy, information in ancient
books recommending the use of many plants against snakebite
is highly inspiring. Degradation of hyaluronan by venom hyal-
uronidase during natural envenomation increases the easy dif-
fusion of venom toxins, which otherwise would have diffused
Table 1 ELISA titers and in vitro neutralization of crude Cc
hyaluronidase activity by anti-CcHaseII.
Weeks ELISA titer % Neutralization of
hyaluronidase activity
1 1:100 43
2 1:50 33
3 1:40 21
4 1:4600 44
5 1:1600 24
6 1:1000 20
7 1:5500 67
8 1:4500 48
9 1:4000 25
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reduction in the spread of toxins [14].
3.1. Detection of antibodies and immunoreactivity of anti-
CcHaseII with Cc venom
The anti-CcHaseII prepared in rabbit showed different levels
of immunoreactivity with whole venom in indirect ELISA at
a week interval after injection. The ELISA titer of anti-CcHa-
seII against Cc venom increased signiﬁcantly across weeks
intervals, and showed the highest titer of 1:5500 in the 7th
week (Table 1) which is less than the titer of the prepared
anti-NNH1 antiserum against NN venom (1:8000) [13]. The
pre-immune rabbit serum did not reveal any titer. In addition,
the in vitro neutralization of hyaluronidase activity of the Cc
venom by using the anti-CcHaseII showed the maximum of
67% at the 7th week. A good correlation, r= 0.65, was found
between the in vitro hyaluronidase neutralization values and
the ELISA titers of anti-CcHaseII against the corresponding
venom at 1st, 4th and 7th weeks, suggesting that the antiserum
in these periods more avid because more antigenic epitopes
were involved. A set of high correlations was reported for
the neutralization of speciﬁc venom activities with ELISA ti-
ters [1,42]. The success of toxin neutralization by antivenomTable 2 Inhibition of hyaluronidase activity of Cc venom by various
Plant extracts Plant family
None –
Cuminum cyminum Apiaceae
Foeniculum vulgare Apiaceae
Pimpinella anisum Apiaceae
Ceratonia siliqua Fabaceae
Glycyrrhiza glabra Fabaceae
Tamarindus indica Fabaceae
Mentha peprinta Lamiaceae
Ocimum basilicum Lamiaceae
Origanum majorana Lamiaceae
Rosmarinus oﬃcinalis Lamiaceae
Thymus mongolicus Lamiaceae
Hibiscus sabdariﬀa Malvaceae
Sesamum indicum Pedaliaceae
Hordeum vulgare Poaceae
Nigella sativa Ranunculaceae
Curcuma longa Zingiberaceae
Zingiber oﬃcinale Zingiberaceaedepends on the abundance of speciﬁc antibody against the
principle lethal toxin of the venom also on its binding afﬁnity
for the toxin [19,45].
3.2. Inhibition of Cc hyaluronidase activity by plant extracts
An important point of this work was the manner in which the
neutralizing effects of plant extracts against snake venoms
evaluated. Neutralization studies could be performed by
adopting two basic strategies: (1) Pre-incubation of venom
and antivenom prior to testing and (2) Injecting venom fol-
lowed by anti-venom or plant extract separately to experimen-
tal mice [15,21]. In case of screening the active plant extracts
against venom, we have used pre-incubation method. In Ta-
ble 2, the initial screening studies involving aqueous extracts
of different parts (leaf, seed and ﬂower) of 17 commonly
medicinal herbs belonging to different plant families against
Cc hyaluronidase activity at (venom: extract) ratio of 1:10
(w/w), only the aqueous extract of R. ofﬁcinalis (Ro) com-
pletely inhibited the hyaluronidase activity of Cc venom. In
addition, the aqueous extracts of Mentha peprinta < Ocimum
basilicum < Origanum majorana < R. ofﬁcinalis belong to the
same Lamiaceae family inhibited the hyaluronidase activity of
Cc venom to a varied extent. Lamiaceae family consists mainly
of herbs containing essential oil, but also shrubs, trees and lia-
nas are represented. It made up of 236 genera and 7173 species
that are abundant in pharmacopoeias throughout the world
[4,5]. The herbal remedy of Lamiaceae species most often used
against snakebite is a decoction or a poultice of primarily
leaves, but all parts are used either orally or externally [3,36].
3.3. Dose dependent inhibition of CcHaseII and Cc venom
hyaluronidase activity
Different concentrations of aqueous Ro-extract were pre-incu-
bated with Cc venom to inhibit its hyaluronidase activity. Inhi-
bition of 50% of the hyaluronidase activity (IC50) and the
100% (complete inhibition) were achieved at a ratio of 1:1.2
and 1:8 (w/w) of Cc venom: Ro extract respectively, (Fig. 1).
In addition, IC50 and 100% inhibition were achieved at a ratioaqueous plants extracts at a venom: extract ratio of 1:10 in vitro.
Plant parts Inhibition %
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Figure 1 Inhibition of hyaluronidase activity of Cc (10 lg) and
the puriﬁed CcHaseII (1.75 lg) were preincubated separately with
various watery RO extract for 15 min at 37 C. The mixture was
added to 50 lg of hyaluronic acid in 0.2 M sodium acetate buffer,
pH 5.5 containing 0.15 M NaCl at 37 C ,then hyaluronidase
activity was carried out as described in Section 2. The values
represent mean ± SEM (n= 3).
Table 3 Effect of hyaluronidase inhibition using Ro extract
on hemorrhagic activity of CcHT1 + CcHaseII mixture.
Number Samples
injected (w/w)
Hemorrhagic
spot (mm)
a 1U of CcHT1 (1.9 lg) alone 10 ± 1
b 1U of CcHT1 + CcHaseII (1U) 22 ± 2
c 1U of CcHT1 + CcHaseII
(1U) + Ro extract (50 ll)
0
d Ro extract alone (50 ll) 0
e CcHaseII alone (1U) 0
f Saline alone (100 ll) 0
Values represent mean ± SEM (n= 2).
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Figure 3 Inhibition of the edema inducing activity of Cc venom.
The 2 MED of crude venom (8 lg) was preincubated with different
concentrations of Ro extract in a total volume of 100 ll saline for
15 min at 37 C and injected into the right footpads of mice. The
mice were anesthetized and scariﬁed after 1 h and the edema ratio
was calculated. The values represent mean ± SEM (n= 5).
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(Fig. 1). In previously study, the prepared anti-CcHaseII inhib-
ited in vitro the hyaluronidase activity of puriﬁed CcHaseII
and crude Cc venom in a dose-dependent manner. The
(IC50) and 100% inhibition were achieved at a ratio 1: 4 and
1:32 (w/w) of crude Cc venom: anti-CcHaseII, respectively.
In addition, IC50 and 100% inhibition were achieved at a ratio
1: 1.2 and 1:16 (w/w) of the puriﬁed CcHaseII: anti-CcHaseII,
respectively [51]. Both anti-NNH1 and aristolochic acid inhib-
ited the hyaluronidase activity of puriﬁed hyaluronidase,
(NNH1) and of whole Naja naja venom in a dose-dependent
manner [13]. Furthermore, the methanolic extracts of Vitis
vinifera and Andrographis paniculata have shown 100% and
59% of hyaluronidase inhibition of Vipera russeli and N. naja
venoms at venom: extract ratio of 1:2 and 1:20, respectively
[18,30].
3.4. Inhibition of spreading property of CcHaseII
In rabbit co-injected with the puriﬁed hemorrhagic CcHTI and
CcHaseII, hemorrhagic activity was approximately twice that
of rabbit injected with hemorrhagic CcHTI alone 10 ± 1,
22 ± 2 mm, respectively. Rabbit co-injected with hemorrhagic
CcHTI and CcHaseII that had been pre-incubated with Ro ex-Figure 2 Inhibition of spreading property of puriﬁed CcHaseII on hem
developed in the skin of rabbits with doses of (a) 1U (1.9 lg) of CcHT
CcHaseII pre-incubated with Ro extract (50 ll) (d,e,f). CcHaseII (1U)tract completely neutralized the diameter of hemorrhagic spot
(Table 3, Fig. 2). Therefore, Ro. not only neutralized the
CcHaseII hyaluronidase activity but also neutralized the
CcHTI hemorrhagic activity. It suggests that Ro. may contain
an endogenous inhibitor of venom-induced hemorrhage might
chelate the metal ion or interact with a speciﬁc domain to
inactivate the hemorrhagic protease, and that could have led
to inhibition of the hemorrage. Similarly, the aqueous extract
of Hibiscus aethiopicus totally inhibited the hemorrhagicorrhagic activity according to Kondo et al. (1960). The spots were
1, (b) 1U of CcHT1 + (1U) CcHaseII, (C) 1U of CcHT1 + (1U)
, Ro extract (50 ll), and Saline (100 ll) servers as controls.
Table 4 Effect of anti-CcHaseII and Ro extract on the
survival time of mice injected with 2LD50 of the Cc venom.
Groups Samples injected (w/w) Survival time (min)
I Cc venom (2LD50) 15 ± 5
IIa Cc venom+ anti-CcHaseII (1:20) 25 ± 5
IIb Cc venom+ anti-CcHaseII (1:40) 45 ± 8
IIc Cc venom+ anti-CcHaseII (1:80) 55 ± 4
IId Cc venom+ anti-CcHaseII (1:160) 60 ± 3
IIe Cc venom+ anti-CcHaseII (1:320) 75 ± 4
IIIa Cc venom+ Ro extract (1:20) 56 ± 2
IIIb Cc venom+ Ro extract (1:40) 97 ± 7
IIIc Cc venom+ Ro extract (1:80) 125 ± 3
IIId Cc venom+ Ro extract (1:160) 243 ± 8
IIIe Cc venom+ Ro extract (1:320) 439 ± 7
Iv Anti-CcHaseII (0:320) All alive
V Ro extract (0:320) All alive
VI Saline All alive
Values are mean ± SEM (n = 5).
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nolic extract of V. vinifera effectively neutralized the hemor-
rhagic activity of Vipera russilli venom at the venom: extract
ratio of 1:25 [30]. However, the prepared anti-CcHaseII at
(50, 100 ll) decreased the diameter of hemorrhagic spots in-
duced by mixture of 1U of hemorrhagic CcHTI + 1U of
CcHaseII from 22.2 to 10, 8 mm, respectively, [51]. No hemor-
rhage was observed in rabbit injected with CcHaseII, Ro ex-
tract, or saline alone (Table 3, Fig. 2).
3.5. Neutralization of Cc edema-inducing activity
The edema-forming activity was assessed for Cc, and Ro ex-
tract was found to be effective in the neutralization of edema
induced by venom (Fig. 3). The edema ratio due to 2 MED
is neutralized from 150 ± 5% to 115 ± 2% by Ro-extract at
1:50 (w/w) ratio, suggesting the inhibition of inﬂammatory
reactions, most likely phospholipase A2 activity of the venom.
Grape seeds extract completely abolished the edema induced
by the Daboia russelli venom dose-dependently and at the ve-
nom extract ratio of 1:20 the edema ratio due to 6MED of
170 ± 2% neutralized to 117 ± 3.1% [30]. In addition, theFigure 4 The effect of Ro extract on internal hemorrhage induced by
CcHaseII (B), Cc followed with Ro extract (c) saline alone as controledema ratio % due to 2 MED of Cc crude venom is neutralized
from 150% to 110% by the prepared anti-CcHaseII at 1:100
ratio [51].
3.6. Effect of anti-CcHaseII and Ro extract on survival time of
mice injected with Cc venom
Herbal compounds that possess snake venom neutralization
properties in experimental animal usually apply the protocol
of venom followed by herbal compound because this technique
is similar to clinical conditions; therefore, we have used this
protocol. In Table 4, when mice were injected (i.p.) with Cc ve-
nom (2LD50) followed by anti-CcHaseII (Group II) or the
aqueous Ro extract (Group III), the survival time of each
group was increased compared to mice injected with (2LD50)
of Cc venom alone (Group I). Both the anti-CcHaseII and
Ro extract showed a dose-dependent effect, and the survival
time increased from 15 ± 5 min (Group I) to a maximum of
75 ± 4 min at venom: anti-CcHaseII ratio of 1:320 (w/w), we
found a little effect on survival time during additional increas-
ing in the anti-CcHaseII concentrations. However, the Ro ex-
tract increased the survival time from 15 ± 5 min to a
maximum of 439 ± 7 min at venom: Ro extract ratio of
1:320 (w/w). Hence, the Ro extract retard the time death up
to 7 h. however, mice injected with anti-CcHaseII (Group
IV), Ro extract (Group V) alone, and saline were all alive in
the experiment time. The internal hemorrhage induced by Cc
venom was less prominent in the presence of Ro extract
(Fig. 4). Similarly, the methanol extract of A. paniculata has
shown a signiﬁcant inhibition on neurotoxic symptoms caused
by the N. naja venom and prolonged the survival time of mice
(22 ± 2 g) to 14.44 ± 0.55 h at the venom: extract ratio of
1:500 [18]. Similar results were observed by different plant ex-
tracts and bioactive components [7,31,37,46].
4. Conclusion
Hence, inhibitors of hyaluronidase are of great interest as they
could stop or delay the diffusion of toxins after the natural
envenomation. The natural herbal remedies are showing prom-
ising expectations against snakebite. The aqueous rosemary ex-
tract is cheap, easily available, stable at room temperature andCc venom. Mice injected with: Cc alone (A), Cc followed with anti-
(D), respectively.
Role of hyaluronidase inhibitors in the neutralization of toxicity of Egyptian horned viper Cerastes cerastes venom 219could strongly neutralize many local effects of Cc venom. We
have not found any studies done on its effect in inhibiting the
spreading property of the venom of either the selected Cc viper
or any snake species. Therefore, the application of the aqueous
rosemary extract might be useful as ﬁrst aid treatment for vic-
tims of snakebites, complete action of antivenom. In addition,
application of such inhibitors at the site of a bite may minimize
mortality and morbidity while transporting the patient to re-
ceive anti-venom therapy.
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